Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Wilson

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Archives of General Psychiatry|February 8, 2012
Influence of patient race and ethnicity on clinical assessment in patients with affective disordersMichael A Gara, William A Vega, Stephan Arndt, et al.
Psychiatric Services (Washington, D.C.)|August 2, 2016
Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention StudyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.
Schizophrenia Bulletin|May 30, 2014
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE studyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.
Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Schizophrenia Research|January 12, 2023
Longitudinal study of inflammation and relapse in schizophreniaBrian J Miller, Henrique Lemos, Nina R Schooler, et al.
Schizophrenia Research|July 24, 2017
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?Anilkumar Pillai, Nina R Schooler, Diya Peter, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Archives of General Psychiatry|February 8, 2012
Influence of patient race and ethnicity on clinical assessment in patients with affective disordersMichael A Gara, William A Vega, Stephan Arndt, et al.
Psychiatric Services (Washington, D.C.)|August 2, 2016
Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention StudyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.
Schizophrenia Bulletin|May 30, 2014
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE studyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.
Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.
Schizophrenia Research|January 12, 2023
Longitudinal study of inflammation and relapse in schizophreniaBrian J Miller, Henrique Lemos, Nina R Schooler, et al.
Schizophrenia Research|July 24, 2017
Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?Anilkumar Pillai, Nina R Schooler, Diya Peter, et al.
Pageof 4